Exact Sciences (EXAS) Price Target Raised to $26 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs maintained a Buy rating on Exact Sciences (NASDAQ: EXAS) and raised its price target to $26.00 (from $19.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
